Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125494721 | 12549472 | 1 | I | 20160607 | 20160701 | 20160712 | 20160712 | EXP | LM20160662 | FR-VALIDUS PHARMACEUTICALS LLC-FR-2016VAL002258 | VALIDUS | 62.00 | YR | F | Y | 0.00000 | 20160711 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125494721 | 12549472 | 1 | PS | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | UNK | Y | 16273 | TABLET | ||||||||
| 125494721 | 12549472 | 2 | SS | BISOPROLOL FUMARATE. | BISOPROLOL FUMARATE | 1 | Oral | UNK | Y | 0 | |||||||||
| 125494721 | 12549472 | 3 | SS | CEREBREX | CALCIUM GLYCEROPHOSPHATECALCIUM PHOSPHATEGLUTAMIC ACIDVITAMIN B | 1 | Oral | UNK | Y | 0 | |||||||||
| 125494721 | 12549472 | 4 | SS | VOLTAREN | DICLOFENAC SODIUM | 1 | Oral | UNK | Y | 0 | |||||||||
| 125494721 | 12549472 | 5 | C | PRADAXA | DABIGATRAN ETEXILATE MESYLATE | 1 | U | 0 | |||||||||||
| 125494721 | 12549472 | 6 | C | ACUPAN | NEFOPAM HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 125494721 | 12549472 | 7 | C | TIMOFEROL | ASCORBIC ACIDFERROUS SULFATE | 1 | U | 0 | |||||||||||
| 125494721 | 12549472 | 8 | C | BRICANYL | TERBUTALINE SULFATE | 1 | U | 0 | |||||||||||
| 125494721 | 12549472 | 9 | C | SINGULAIR | MONTELUKAST SODIUM | 1 | U | 0 | |||||||||||
| 125494721 | 12549472 | 10 | C | LYRICA | PREGABALIN | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125494721 | 12549472 | 1 | Product used for unknown indication |
| 125494721 | 12549472 | 2 | Arrhythmia |
| 125494721 | 12549472 | 3 | Arthralgia |
| 125494721 | 12549472 | 4 | Arthralgia |
| 125494721 | 12549472 | 5 | Product used for unknown indication |
| 125494721 | 12549472 | 6 | Product used for unknown indication |
| 125494721 | 12549472 | 7 | Product used for unknown indication |
| 125494721 | 12549472 | 8 | Product used for unknown indication |
| 125494721 | 12549472 | 9 | Product used for unknown indication |
| 125494721 | 12549472 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125494721 | 12549472 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125494721 | 12549472 | Acute kidney injury | |
| 125494721 | 12549472 | Bradycardia | |
| 125494721 | 12549472 | Hyperkalaemia | |
| 125494721 | 12549472 | Hypotension | |
| 125494721 | 12549472 | Ventricular tachycardia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125494721 | 12549472 | 1 | 20160609 | 0 | ||
| 125494721 | 12549472 | 2 | 20160609 | 0 | ||
| 125494721 | 12549472 | 3 | 201605 | 20160609 | 0 | |
| 125494721 | 12549472 | 4 | 201605 | 20160609 | 0 |